Expert Insights Webinars


        Award-winning experts share their detailed and actionable insights to inform 

        the future of pharma, biotech, and medical devices.


        Strategies for Navigating ICH E9(R1)

        Strategies for Navigating ICH E9(R1): Considerations for Using Estimands and Sensitivity Analysis in Clinical Trials

        The ICH E9(R1) Addendum on 'Estimands and Sensitivity Analysis in Clinical Trials' introduced a framework to align planning, design, conduct, analysis, and interpretation of clinical trials.  

        Tuesday, May 3 at 10:00 AM - 12:00 PM EST


        Title Slide - 12.14-1

        Tips for Effective and Efficient New Drug Application (NDA) Submissions

        HubSpot Video

        Getting the Most Out of Data Visualizations in Pharma and Biotech

        HubSpot Video

        Strategies for Rare Disease Data Analysis: Doing More with Less

        HubSpot Video

        Orphan Drug, Rare Pediatric Disease and Expedited Program Designations

        HubSpot Video

        Rare Disease Research in the United States, Part 2

        HubSpot Video

        Rare Disease Research in the United States, Part 1

        Changes for Pharma Companies in Response to COVID-19 Webinar Graphic

        The Blueprint for Success for Effective and Efficient Clinical Protocols

        HubSpot Video

        EU Clinical Trials Regulation: The Clinical Trial Transparency Revolution

        HubSpot Video

        Avoiding Common Pitfalls in the IND and CTA Submission Process

        HubSpot Video

        Evolving Your FSP Relationships to Achieve Maximum Return

        HubSpot Video

        How to Use Machine Learning in Clinical Research Right Now